SELANCIA 10 mg
Selank
A tuftsin-derived synthetic heptapeptide investigated in neurochemical and stress-response signaling.
This product is being prepared for release. Pricing and availability will be confirmed before ordering opens.
Every compound vial includes one 3 mL BAC Water and one compound / BAC pair holder.
Research Use Only (RUO)
For controlled laboratory and analytical research only. Not for human or veterinary use. Study findings describe experimental materials and models, not verified effects of this product.
What is SELANCIA?
SELANCIA supplies Selank, a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin and extended with a Pro-Gly-Pro sequence. Its experimental research includes neurochemical and regulatory-peptide signaling.
Animal studies have examined changes in genes involved in GABAergic neurotransmission and related neural pathways. These findings do not establish anxiety treatment, emotional stabilization or an absence of sedation or other adverse effects in humans.
Specifications & reporting
- Compound
- Selank
- Selected vial amount
- 10 mg
- Format
- Lyophilized research material
- Batch / lot
- Not assigned
- COA
- Pending · no batch results posted
No purity, net-content or batch-testing result is claimed before a matching laboratory report is posted. Handling and stability depend on the material and experimental conditions; confirm lot-specific documentation before laboratory work.
Product labels
Black, silver and teal artwork with blank LOT / MFG / EXP fields. Packaging concept, 40 × 20 mm layout.
Selected research
References are provided for research context. They do not establish the safety or efficacy of this product for human use.